G. Kaltenecker

Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes

C. Denkert, M. Dietel, S. Loibl, 2014, BMC Cancer.

Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes

C. Denkert, M. Dietel, S. Loibl, 2014, BMC Cancer.

A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients

J. Heil, S. Kuemmel, J. Blohmer, 2020, Annals of surgery.

AXSANA – AXillary Surgery After NeoAdjuvant Treatment (EUBREAST-3): current status of the international prospective multicenter cohort study evaluating different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655

T. Kühn, E. Schlichting, E. Stickeler, 2022, Senologie - Zeitschrift für Mammadiagnostik und -therapie.

Axillary Staging after Neoadjuvant Chemotherapy for Initially Node-Positive Breast Carcinoma in Germany

M. Lux, T. Kühn, S. Loibl, 2021, Geburtshilfe und Frauenheilkunde.

Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients

N. Harbeck, O. Gluz, O. Stoetzer, 2020, Breast Care.

Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study

K. Friedrichs, N. Harbeck, O. Gluz, 2019, Breast Cancer Research and Treatment.

Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study

E. Stickeler, J. de Boniface, M. Kontos, 2023, Breast Cancer Research and Treatment.